Game-changing weekly semaglutide therapy launched at unprecedented affordability ‘SUNDAE’ aims to bring advanced GLP-1 treatment within reach of 70% of patients Multi-dose vials now; convenient pen-device rollout slated for April Big leap in tackling India’s twin epidemics—Type 2 Diabetes & obesity NE HEALTH BUREAU AHMEDABAD, MAR 20 In a landmark move set to reshape diabetes … Continue reading ₹220 per shot, a health revolution: Eris unlocks next-gen diabetes care for millions